{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:51:12Z","timestamp":1768917072002,"version":"3.49.0"},"reference-count":30,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.3892\/or.2014.3045","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T11:40:14Z","timestamp":1392896414000},"page":"1825-1831","source":"Crossref","is-referenced-by-count":34,"title":["CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer"],"prefix":"10.3892","volume":"31","author":[{"given":"TIANREN","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI","family":"XUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YI","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEJUN","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"key":"key20180107222348_b1-or-31-04-1825","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20180107222348_b2-or-31-04-1825","first-page":"53","article-title":"Ovarian carcinoma: current diagnostic principles","volume":"46","author":"Dundr","year":"2010","journal-title":"Cesk Patol"},{"key":"key20180107222348_b3-or-31-04-1825","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/beog.2002.0300","article-title":"Pathology of borderline (low malignant potential) ovarian tumours","volume":"16","author":"Seidman","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20180107222348_b4-or-31-04-1825","doi-asserted-by":"crossref","first-page":"909vii","DOI":"10.1016\/S0889-8588(03)00061-3","article-title":"Pathology of ovarian carcinoma","volume":"17","author":"Seidman","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107222348_b5-or-31-04-1825","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.anndiagpath.2009.03.005","article-title":"High-grade serous carcinoma of the ovary","volume":"13","author":"Westfall","year":"2009","journal-title":"Ann Diagn Pathol"},{"key":"key20180107222348_b6-or-31-04-1825","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"key20180107222348_b7-or-31-04-1825","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10555-011-9326-8","article-title":"Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance","volume":"31","author":"Tarin","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107222348_b8-or-31-04-1825","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20082234","article-title":"Dual-specificity phosphatases: critical regulators with diverse cellular targets","volume":"418","author":"Patterson","year":"2009","journal-title":"Biochem J"},{"key":"key20180107222348_b9-or-31-04-1825","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-4159.2004.02414.x","article-title":"Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene","volume":"89","author":"Niculescu","year":"2004","journal-title":"J Neurochem"},{"key":"key20180107222348_b10-or-31-04-1825","first-page":"4697","article-title":"Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma","volume":"60","author":"Yeh","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107222348_b11-or-31-04-1825","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-291X(03)00757-5","article-title":"Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant","volume":"305","author":"Yeh","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107222348_b12-or-31-04-1825","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ijc.21735","article-title":"E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition","volume":"119","author":"Blum","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107222348_b13-or-31-04-1825","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/35106593","article-title":"The E2F1-3 transcription factors are essential for cellular proliferation","volume":"414","author":"Wu","year":"2001","journal-title":"Nature"},{"key":"key20180107222348_b14-or-31-04-1825","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000133960","article-title":"Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3)","volume":"69","author":"Demetrick","year":"1995","journal-title":"Cytogenet Cell Genet"},{"key":"key20180107222348_b15-or-31-04-1825","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1755-8794-3-16","article-title":"MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients","volume":"3","author":"MacDermed","year":"2010","journal-title":"BMC Med Genomics"},{"key":"key20180107222348_b16-or-31-04-1825","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2012.02.107","article-title":"Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation","volume":"420","author":"Xing","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107222348_b17-or-31-04-1825","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr2593","article-title":"Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer","volume":"12","author":"Taylor","year":"2010","journal-title":"Breast Cancer Res"},{"key":"key20180107222348_b18-or-31-04-1825","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urolonc.2010.09.010","article-title":"Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells","volume":"30","author":"Lai","year":"2012","journal-title":"Urol Oncol"},{"key":"key20180107222348_b19-or-31-04-1825","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2184.2011.00752.x","article-title":"Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis\/cirrhosis and hepatocellular carcinoma (HCC) transformation","volume":"44","author":"Wang","year":"2011","journal-title":"Cell Prolif"},{"key":"key20180107222348_b20-or-31-04-1825","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4161\/cbt.25966","article-title":"p19 mRNA and protein expression as new prognostic factor in ovarian cancer patients","volume":"14","author":"Felisiak-Golabek","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"key20180107222348_b21-or-31-04-1825","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000349892","article-title":"Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer","volume":"75","author":"No","year":"2013","journal-title":"Gynecol Obstet Invest"},{"key":"key20180107222348_b22-or-31-04-1825","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1038\/cddis.2013.256","article-title":"KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis"},{"key":"key20180107222348_b23-or-31-04-1825","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1158\/1078-0432.CCR-03-0751","article-title":"Cyclin D1, p53, and p21Waf1\/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer","volume":"10","author":"Bali","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107222348_b24-or-31-04-1825","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/MCB.20.5.1723-1732.2000","article-title":"Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression","volume":"20","author":"Lee","year":"2000","journal-title":"Mol Cell Biol"},{"key":"key20180107222348_b25-or-31-04-1825","doi-asserted-by":"crossref","first-page":"17235","DOI":"10.1074\/jbc.M413437200","article-title":"Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP). Cdk2cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2","volume":"280","author":"Chinami","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107222348_b26-or-31-04-1825","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/0008-5472.CAN-06-2478","article-title":"Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107222348_b27-or-31-04-1825","doi-asserted-by":"crossref","first-page":"e34456","DOI":"10.1371\/journal.pone.0034456","article-title":"Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"key20180107222348_b28-or-31-04-1825","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/374386a0","article-title":"Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA","volume":"374","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"key20180107222348_b29-or-31-04-1825","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/bst0290385","article-title":"The mechanism of protein kinase regulation by protein phosphatases","volume":"29","author":"Barford","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"key20180107222348_b30-or-31-04-1825","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0163-7258(02)00181-X","article-title":"Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2","volume":"93","author":"Johnson","year":"2002","journal-title":"Pharmacol Ther"}],"updated-by":[{"DOI":"10.3892\/or.2025.9008","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"record-id":"68842"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3045\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:32:41Z","timestamp":1515364361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,2,20]]},"published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.3892\/or.2014.3045"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3045","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,20]]}}}